Human medicines European public assessment report (EPAR): Rhokiinsa, netarsudil, Glaucoma, Open-Angle,Ocular Hypertension, Date of authorisation: 19/11/2019, Status: Authorised
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):